COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography

Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our objective was to determine if fibrinolysis stimulated by tissue plasminogen activator (tPA) differed between COVID pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Maier, Cheryl L., Sarker, Tania, Szlam, Fania, Sniecinski, Roman M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026096/
https://www.ncbi.nlm.nih.gov/pubmed/33829396
http://dx.doi.org/10.1007/s11239-021-02438-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026096/
https://www.ncbi.nlm.nih.gov/pubmed/33829396
http://dx.doi.org/10.1007/s11239-021-02438-y

Ejemplares similares